4 out of 5 treated eyes show an increased thickness of the Retinal Nerve Fiber Layer

An Effective Solution

Recent clinical trial data shows an IOP reduction from baseline of >30%

Use for most glaucoma variants

Meet Our Team

DONALD SCHWARTZ, OD, MD

President and Founder

ERIC SCHULTZ, MS

CEO, CTO and Co-Founder

OMID KHODAI, OD, MS

Clinical & Regulatory

EyeSonix's team strives to extend "sighted life" worldwide by making available a simple and highly effective glaucoma treatment, breaking the paradigm of present day glaucoma care.

ALAN ROBIN, MD, PA

Clinical Advisor

VINCENT M. PATELLA, OD

Medical Advisor

JOHN SAMPLES, MD

Medical Advisor

JAGDEEP KAKADIA, MD, PhD

Medical Advisor

DARYL MICHALIK, MBA

Business Development

STEPHANIE KAPLAN, MBA

Operations & Quality

RAMESH SHAH, MD

Medical Advisor

Contact Us

If you're interested in hearing more about the technology, have a business proposal, or are interested in making a purchase, we'd love to hear from you.